Drugs

Indus Biotech is a drug development company which develops innovative health solutions and drugs of botanical origin as candidates for US FDA approval, either as NCEs or as botanical drugs.

The Company has a deep pipeline of products under various stages of development and is currently seeking partnerships with companies that can:

1. Fund further development of a drug candidate for a share of the IP
2. Undertake co-development, on a shared IP basis
3. Out-license
4. Purchase an IP outright

Finished Formulations Marketing and Sales

Indus has developed finished formulations for chronic diseases such as diabetes, pre-diabetes, rheumatoid arthritis, etc. These products are currently marketed as herbal medicines / dietary supplements. These products are supported with regulatory documentation that covers extensive toxicology, clinical efficacy and chemistry and manufacturing control (CMC).

Partners chosen by invitation

1. Deep pipeline in most sought after segments
2. Well established ethical product companies
3. Exclusivity in exchange for royalty for IPR

Indus will provide

1. Final dosage form
2. Regulatory approval dossiers
3. Product samples
4. Training inputs for sales and marketing staff

If you or your company can partner successfully with Indus in any of the areas mentioned above,
write in to us - partnering@indusbiotech.com